Cambridge-founded automated cell analytics platform Sphere Fluidics has added $2m of funding, bringing its lifetime haul to $14.9m.

Sphere Fluidics, a UK-based automated cell analysis system spinout of University of Cambridge, closed a $2m round on Wednesday backed by investment firm Greenwood Way Capital.
24Haymarket also supplied capital, as did investment manager Oxford Technology and Innovations EIS Fund.
Sphere Fluidics has devised an automated cell analytics platform branded Cyto-Mine that is able to screen, sort, image and verify individual cells for purposes including antibody discovery projects.
Cyto-Mine has a maximum daily processing capacity of 40…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?